Clearside Biomedical Inc
NASDAQ:CLSD 4:00:00 PM EDT
Earnings Announcements
Clearside Biomedical Has About $48.3 Mln Of Cash, Cash Equivalents
Published: 02/02/2023 14:37 GMT
Clearside Biomedical Inc (CLSD) - Clearside Biomedical - As of December 31, 2022, We Had Approximately $48.3 Million of Cash and Cash Equivalents.
Further Company Coverage: Clsdo ((reuters.
Briefs@thomsonreuters.
Com;)).
Further Company Coverage: Clsdo ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0.15 Million
Adjusted EPS is expected to be -$0.14
Next Quarter Revenue Guidance is expected to be $0.15 Million
Next Quarter EPS Guidance is expected to be -$0.14
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.14
Next Quarter Revenue Guidance is expected to be $0.15 Million
Next Quarter EPS Guidance is expected to be -$0.14
More details on our Analysts Page.